← FDA Drug Approvals (Drugs@FDA)
DIAZOXIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: E5 PHARMA INC · Approved 2019-12-20
Drug application
- FDA Application #
ANDA211050- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DIAZOXIDE
- Generic name
- DIAZOXIDE
- Active ingredients
- DIAZOXIDE
- Dosage form
- SUSPENSION
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- E5 PHARMA INC
- Manufacturer
- e5 Pharma, LLC
- First approval
- 2019-12-20
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown